Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community

Diseases of the Esophagus

Volumn 25, Issue 7, 2012, Pages 573-583

  Pandeya, N ^a,b   Green, Adele C ^b,c   Whiteman, David C ^c   Webb, Penelope M ^c   Hayward, Nicholas K ^c   Parsons, Peter G ^c   Purdie, David M ^c   Smithers, B Mark ^c   Gotley, David ^c   Clouston, Andrew ^c   Brown, Ian ^c   Moore, Suzanne ^c   Harrap, Karen ^c   adkowski, Troy ^c   O'Brien, Suzanne ^c   Minehan, Ellen ^c   Roffe, Deborah ^c   O'Keefe, Sue ^c   Lipshut, Suzanne ^c   Connor, Gabby ^c   Berry, Hayley ^c   Walker, Frances ^c   Barnes, Teresa ^c   Thomas, Janine ^c   Terry, Linda ^c   Connard, Michael ^c   Bowes, Leanne ^c   Malt, Mary Rose ^c   White, Jo ^c   Mosse, Charles ^c   Tait, Noel ^c   Bambach, Chris ^c   Biankan, Andrew ^c   Brancatisano, Roy ^c   Coleman, Max ^c   Cox, Michael ^c   Deane, Stephen ^c   Falk, Gregory L ^c   Gallagher, James ^c   Hollands, Mike ^c   Hugh, Tom ^c   Smith, Ross ^c   Storey, David ^c   Avramovic, John ^c   Croese, John ^c   D'Arcy, Justin ^c   Fairley, Stephen ^c   Hansen, John ^c   Masson, John ^c   Nathanson, Les ^c   O'Loughlin, Barry ^c   Rutherford, Leigh ^c   Turner, Richard ^c   Windsor, Morgan ^c   Bessell, Justin ^c   Devitt, Peter ^c   Jamieson, Glyn ^c   Watson, David ^c   Blamey, Stephen ^c   Boussioutas, Alex ^c   Cade, Richard ^c   Crosthwaite, Gary ^c   Faragher, Ian ^c   Gribbin, John ^c   Hebbard, Geoff ^c   Kiroff, George ^c   Mann, Bruce ^c   Millar, Bob ^c   O'Brien, Paul ^c   Thomas, Robert ^c   Wood, Simon ^c   Archer, Steve ^c   Faulkner, Kingsley ^c   Hamdorf, Jeff ^c   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c NONE

Author keywords

Body mass index; Cross sectional survey; Gastroesophageal reflux; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHILD; COFFEE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEAT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; SELF REPORT; SMOKING;

EID: 84866290235     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01287.x     Document Type: Article

References (58)

1. Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr 2007; 40: 13-23.
2. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
3. Whiteman D C, Sadeghi S, Pandeya N etal. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173-80.
4. Pandeya N, Webb P M, Sadeghi S, Green A C, Whiteman D C. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAID or acid suppressants? Gut 2010; 59: 31-8.
5. Reimer C, Bytzer P. A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease. Scand J Gastroenterol 2009; 44: 394-400.
6. Dent J, El-Serag H B, Wallander M A, Johansson S. Epidemiology of gastrooesophageal reflux disease: a systematic review. Gut 2005; 54: 710-17.
7. El-Serag H B. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007; 5: 17-26.
8. Watson D I, Lally C J. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community. World J Surg 2009; 33: 88-94.
9. Knox S A, Harrison C M, Britt H C, Henderson J V. Estimating prevalence of common chronic morbidities in Australia. Med J Aust 2008; 189: 66-70.
10. Dore M P, Maragkoudakis E, Fraley K etal. Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci 2008; 53: 2027-32.
11. Ponce J, Vegazo O, Beltran B etal. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Ther 2006; 23: 175-83.
12. Nocon M, Labenz J, Willich S N. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006; 23: 169-74.
13. Kaufman S E, Kaye M D. Induction of gastroesophageal reflux by alcohol. Gut 1978; 19: 336-8.
14. Nebel O T, Fornes M F, Castell D O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
15. Kotzan J, Wade W, Yu H H. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001; 18: 1367-72.
16. Jansson C, Nordenstedt H, Johansson S etal. Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT study). Clin Gastroenterol Hepatol 2007; 5: 1029-34.
17. Zheng Z, Nordenstedt H, Pedersen N L, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007; 132: 87-95.
18. Breckan R K, Paulssen E J, Asfeldt A M, Mortensen L, Straume B, Florholmen J. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in northern Norway. Scand J Gastroenterol 2009; 44: 1060-6.
19. Corley D A, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007; 56: 756-62.
20. Corley D A, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 2619-28.
21. Cohen S, Booth G H. Gastric-acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine. N Engl J Med 1975; 293: 897-9.
22. Pehl C, Pfeiffer A, Wendl B, Kaess H. The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease. Aliment Pharmacol Ther 1997; 11: 483-6.
23. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004; 53: 1730-5.
24. Kubo A, Block G, Quesenberry C P, Buffler P, Corley D A. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer 2009; 61: 607-16.
25. Cross A J, Leitzmann M F, Gail M H, Hollenbeck A R, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007; 4: 1973-84.
26. Ward M H, Sinha R, Heineman E F etal. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997; 71: 14-19.
27. El-Serag H B, Satia J A, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 2005; 54: 11-17.
28. Ruhl C E, Everhart J E. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I epidemiologic followup study. Ann Epidemiol 1999; 9: 424-35.
29. Pandeya N, Williams G M, Green A C, Webb P M, Whiteman D C. Do low control response rates always affect the findings? Assessments of smoking and obesity in two Australian case-control studies of cancer. Aust N Z J Public Health 2009; 33: 312-19.
30. Karatela S, Purdie D M, Green A C, Webb P M, Whiteman D C. Repeatability of self-reported information for population-based studies of cancer. Asian Pac J Cancer Prev 2006; 7: 303-8.
31. Olsen C M, Bain C J, Jordan S J etal. Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2007; 16: 2321-30.
32. Lee J, Chia K S. Use of the prevalence ratio v the prevalence odds ratio as a measure of risk in cross sectional studies. Occup Environ Med 1994; 51: 841.
33. Stromberg U. Prevalence odds ratio v prevalence ratio. Occup Environ Med 1994; 51: 143-4.
34. Zou G Y. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
35. Blizzard L, Hosmer D W. The log multinomial regression model for nominal outcomes with more than two attributes. Biom J 2007; 49: 889-902.
36. Cole S R, Platt R W, Schisterman E F etal. Illustrating bias due to conditioning on a collider. Int J Epidemiol 2010; 39: 417-20.
37. Miller G C, Pan Y. Gastro-oesophageal reflux disease. General practice in Australia, health priorities and policies 1998 to 2008. General Practice Series No. 24. Canberra: Australian Institute of Health and Welfare, 2009; 269-78.
38. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke G R, Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004; 19: 95-105.
39. Ruigomez A, Garcia Rodriguez L A, Wallander M A, Johansson S, Graffner H, Dent J. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004; 20: 751-60.
40. Locke G R, Talley N J, Fett S L, Zinsmeister A R, Melton L J. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642-9.
41. Nilsson M, Johnsen R, Ye W M, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003; 290: 66-72.
42. Murray L, Johnston B, Lane A etal. Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol 2003; 32: 645-50.
43. Jacobson B C, Somers S C, Fuchs C S, Kelly C P, Camargo C A Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340-8.
44. Somi M H, Farhang S, Nasseri-Moghaddam S etal. Prevalence and risk factors of gastroesophageal reflux disease in Tabriz, Iran. Iran J Public Health 2008; 37: 85-90.
45. El-Serag H. Role of obesity in GORD-related disorders. Gut 2008; 57: 281-4.
46. El-Serag H B, Ergun G A, Pandolfino J, Fitzgerald S, Tran T, Kramer J R. Obesity increases oesophageal acid exposure. Gut 2007; 56: 749-55.
47. El-Serag H B, Tran T, Richardson P, Ergun G. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol 2006; 41: 887-91.
48. Ruszniewski P, Soufflet C, Barthelemy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther 2008; 28: 1134-9.
49. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 2004; 39: 1040-5.
50. Collings K L, Pratt F P, Rodriguez-Stanley S, Bemben M, Miner P B. Esophageal reflux in conditioned runners, cyclists, and weightlifters. Med Sci Sports Exerc 2003; 35: 730-5.
51. Soffer E E, Merchant R K, Duethman G, Launspach J, Gisolfi C, Adrian T E. Effect of graded-exercise on esophageal motility and gastroesophageal reflux in trained athletes. Dig Dis Sci 1993; 38: 220-4.
52. Bretagne J F, Richard-Molard B, Honnorat C, Caekaert A, Barthelemy P. Gastroesophageal reflux in the French general population: national survey of 8000 adults. Presse Med 2006; 35: 23-31.
53. Labenz J, Blum A L, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
54. Corley D A, Kubo A, Levin T R etal. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter 2008; 13: 352-60.
55. Nordenstedt H, Nilsson M, Johnsen R, Lagergren J, Hveem K. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (the HUNT study). Helicobacter 2007; 12: 16-22.
56. Raghunath A, Hungin A P S, Wooff D, Childs A. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: 737-9.
57. El-Omar E M. Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut 2006; 55: 144-6.
58. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 34: 29-37.